A Clinical Differentiation of Multisystem Inflammatory Syndrome in Children (MIS-C) & Kawasaki Disease (KD)
INTRODUCTION: With the emergence of the COVID 19 pandemic, a new disease, Multisystem Inflammatory Syndrome in Children (MIS-C), had evolved. Increasing number of children are being reported to have MIS-C in the U.S. & worldwide. In the U.S. there are currently 2617 MISC cases reported. MIS-C &a...
Main Authors: | Estes, Andersen, Macariola, Demetrio |
---|---|
Published: |
Digital Commons @ East Tennessee State University
2021
|
Subjects: | |
Online Access: | https://dc.etsu.edu/asrf/2021/presentations/27 |
Similar Items
-
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
by: Luregn J. Schlapbach, et al.
Published: (2021-05-01) -
Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases
by: R. Ebina-Shibuya, et al.
Published: (2020-08-01) -
Two adult cases of multisystem inflammatory syndrome associated with SARS-CoV-2
by: Karolina Mieczkowska, BS, et al.
Published: (2021-04-01) -
COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar
by: Mohammad Rubayet Hasan, et al.
Published: (2021-06-01) -
Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
by: Caterina Matucci-Cerinic, et al.
Published: (2021-06-01)